HAI-ROBOTICS
24.3.2022 13:59:10 CET | Business Wire | Press release
HAI ROBOTICS will display its Autonomous Case-handling Robot (ACR) systems in Europe at the upcoming Transport and Logistics Innovation Week (SITL) 2022 in Paris from Apr. 5-8, an event it sees as the launchpad into more European countries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220324005462/en/
SITL 2022 will also mark the debut of the company's local European team.
Considered a disruptive innovator, HAI ROBOTICS is committed to spearheading the future of warehouse automation, with a flexible, easily deployable and cost-effective solution that will massively increase supply chain efficiency in Europe.
Local Presence
Since setting up its regional headquarters in the Netherlands in late 2021, HAI ROBOTICS has expanded its presence quickly into several countries, such as France, Germany, Spain, Italy, the Benelux and the U.K.
It has quickly set up a local team, most of whom are industrial veterans.
Peter Guan, HAI ROBOTICS European General Manager, said HAI Robotics "is dedicated to hiring local top talent in each of the European key regions."
"The company has already employed the services of several native country managers with proven track records in the logistics automation industry. We keep searching for more local talent that can increase the level of our service and support," Mr Guan said.
"We are gearing up to do more exhibitions in Europe," he added.
An expert in building up, structuring and swiftly growing the European business of international companies that want to break into the market, Mr Guan used to be the sales & marketing director at Hikvision for more than ten years.
At SITL 2022, Mr Guan will be joined by Kai Ramadhin, VP of Sales & Marketing Europe, and Thierry Hennebiq, Country Manager France. Both were newly joined.
With more than 20 years of experience in the logistics market, Mr Ramadhin had previously worked with the Dutch corporation Van Riet Material Handling Systems as both interim CEO and the Director of Sales and Marketing.
With more than 10 years of experience in the intralogistics industry, Mr Hennebiq had previously fulfilled roles at the top system integrators in this industry including TGW, Dematic and Vanderlande.
The Better Fit
Compared with existing, especially traditional, warehouse automation solutions, HAI ROBOTICS believe its ACR systems are a better fit for European customers.
Take France, where SITL 2022 convenes, for example. Mr Hennebiq said "huge demand is observed," given the growing demand for logistic services.
"We think our ACR solution can give logistic service suppliers everything they need to optimize their warehouses for massively increased throughput and efficiency," he said.
Mr Ramadhin said HAI ROBOTICS' target industries include mainly 3PL, retail & e-commerce, fashion and FMCG. "Our ACR solution is catered to handle products in these markets."
Compared to logistic service suppliers employing a traditional human labor force, Mr Ramadhin said the ACR systems can "exponentially increase operational efficiency," whilst requiring less time to implement and being more cost-effective than traditional automation solutions.
"HAI ROBOTICS solution provides more flexibility in term of expansion ability, rapid deployment times and so on. So the sweet-spot of our solution is much more attractive," he said.
Mr Ramadhin noted the company is focused on creating a local network of system integrator, installation and service partners, so that any user of ACR systems can expect rapid and high-quality service wherever they are in Europe.
Since its foray into Europe last year, HAI ROBOTICS' presence has been expanding swiftly in the local warehousing logistics sector.
It has paired up with France-based global logistics solutions engineering company Savoye and has inked a strategic partnership with Greece's market leader in intralogistics Voyatzoglou Systems.
At a time when e-commerce booms, the company's ACR solution was deployed at a Micro-Fulfillment Center in Europe, significantly improving the last-mile delivery.
"We aim to provide our customers with high quality service and support, both through our own regional teams, as well as our robust network of installation and service partners," Mr Ramadhin said.
To see HAI ROBOTICS's ACR systems live, please visit booth K81, Paris - Nord Villepinte - Hall 6, during SITL 2022.
ABOUT HAI ROBOTICS
HAI ROBOTICS, the pioneer in Autonomous Case-handling Robot (ACR) systems, is committed to providing efficient, intelligent, flexible, and customized warehouse automation solutions through robotics technology and AI algorithms. It aims to create value for each factory and logistics warehouse. The HAIPICK ACR system, independently developed in 2015, is the world's first of its kind.
Founded in 2016 in Shenzhen, China, HAI ROBOTICS has offices in the U.S., Europe, Japan, Southeast Asia, Hong Kong and Taiwan, serving customers from more than 30 countries and regions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005462/en/
Link:
Social Media:
https://www.facebook.com/HAIROBOTICS/videos/?ref=page_internal
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
